NVO Investor Alert: Bronstein Gewirtz Grossman LLC Announces Opportunity for Novo Nordisk A/S Investors with Substantial Losses to Lead Class Action Lawsuit
The Impact of the Class Action Lawsuit Against Novo Nordisk A/S Introduction NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or “the Company”) (NYSE: NVO) and certain of…